Iranian Journal of Pediatrics

Published by: Kowsar

Treating Neonatal Abstinence Syndrome from Clinical Perspectives

Fatemeh Nayeri 1 , Bita Ebrahim 2 , Mamak Shariat 2 , Hosein Dalili 1 , Majid Kalani 3 , Niloofar Karbasian 2 and Mahdi Sheikh 2 , *
Authors Information
1 Breastfeeding Research Center
2 Maternal, Fetal and Neonatal Research Center, Tehran University of Medical Sciences, Tehran, IR Iran
3 Pediatrics Department, Akbar-Abadi Hospital, Iran University of Medical Sciences, Tehran, IR Iran
Article information
  • Iranian Journal of Pediatrics: August 2017, 27 (4); e6266
  • Published Online: July 25, 2017
  • Article Type: Research Article
  • Received: April 7, 2016
  • Revised: May 27, 2017
  • Accepted: June 17, 2017
  • DOI: 10.5812/ijp.6266

To Cite: Nayeri F, Ebrahim B, Shariat M, Dalili H, Kalani M, et al. Treating Neonatal Abstinence Syndrome from Clinical Perspectives, Iran J Pediatr. 2017 ; 27(4):e6266. doi: 10.5812/ijp.6266.

Copyright © 2017, Iranian Journal of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Jones HE, Finnegan LP, Kaltenbach K. Methadone and buprenorphine for the management of opioid dependence in pregnancy. Drugs. 2012; 72(6): 747-57[DOI][PubMed]
  • 2. Gordon AL, Lopatko OV, Haslam RR, Stacey H, Pearson V, Woods A, et al. Ineffective morphine treatment regimen for the control of Neonatal Abstinence Syndrome in buprenorphine- and methadone-exposed infants. J Dev Orig Health Dis. 2012; 3(4): 262-70[DOI][PubMed]
  • 3. Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010; 363(24): 2320-31[DOI][PubMed]
  • 4. Rayburn WF, Bogenschutz MP. Pharmacotherapy for pregnant women with addictions. Am J Obstet Gynecol. 2004; 191(6): 1885-97[DOI][PubMed]
  • 5. Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA. 2012; 307(18): 1934-40[DOI][PubMed]
  • 6. Results from the 2005 national survey on drug use and health: national findings. 2013;
  • 7. Kocherlakota P. Neonatal abstinence syndrome. Pediatrics. 2014; 134(2)-61[DOI][PubMed]
  • 8. Hudak ML, Tan RC, Committee On D, Committee On F, American Academy of P. Neonatal drug withdrawal. Pediatrics. 2012; 129(2)-60[DOI][PubMed]
  • 9. Finnegan LP, Connaughton JJ, Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addict Dis. 1975; 2(1-2): 141-58[PubMed]
  • 10. McQueen K, Murphy-Oikonen J. Neonatal Abstinence Syndrome. N Engl J Med. 2016; 375(25): 2468-79[DOI][PubMed]
  • 11. Zimmermann-Baer U, Notzli U, Rentsch K, Bucher HU. Finnegan neonatal abstinence scoring system: normal values for first 3 days and weeks 5-6 in non-addicted infants. Addiction. 2010; 105(3): 524-8[DOI][PubMed]
  • 12. Lipsitz PJ. A proposed narcotic withdrawal score for use with newborn infants. A pragmatic evaluation of its efficacy. Clin Pediatr (Phila). 1975; 14(6): 592-4[DOI][PubMed]
  • 13. Ostrea EM, Chavez CJ, Strauss ME. A study of factors that influence the severity of neonatal narcotic withdrawal. J Pediatr. 1976; 88(4 Pt 1): 642-5[PubMed]
  • 14. Green M, Suffet F. The Neonatal Narcotic Withdrawal Index: a device for the improvement of care in the abstinence syndrome. Am J Drug Alcohol Abuse. 1981; 8(2): 203-13[PubMed]
  • 15. Zahorodny W, Rom C, Whitney W, Giddens S, Samuel M, Maichuk G, et al. The neonatal withdrawal inventory: a simplified score of newborn withdrawal. J Dev Behav Pediatr. 1998; 19(2): 89-93[PubMed]
  • 16. Franck LS, Harris SK, Soetenga DJ, Amling JK, Curley MA. The Withdrawal Assessment Tool-1 (WAT-1): an assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediatric patients. Pediatr Crit Care Med. 2008; 9(6): 573-80[DOI][PubMed]
  • 17. Jones HE, Harrow C, O'Grady KE, Crocetti M, Jansson LM, Kaltenbach K. Neonatal abstinence scores in opioid-exposed and nonexposed neonates: a blinded comparison. J Opioid Manag. 2010; 6(6): 409-13[PubMed]
  • 18. Nayeri F, Sheikh M, Kalani M, Niknafs P, Shariat M, Dalili H, et al. Phenobarbital versus morphine in the management of neonatal abstinence syndrome, a randomized control trial. BMC Pediatr. 2015; 15: 57[DOI][PubMed]
  • 19. Strauss ME, Andresko M, Stryker JC, Wardell JN, Dunkel LD. Methadone maintenance during pregnancy: pregnancy, birth, and neonate characteristics. Am J Obstet Gynecol. 1974; 120(7): 895-900[PubMed]
  • 20. Coyle MG, Ferguson A, Lagasse L, Oh W, Lester B. Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants. J Pediatr. 2002; 140(5): 561-4[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments